Similarly, IDH1 and IDH2 mutations (Table 6) occur in 5–20% of AML cases and play a crucial role in leukemogenesis by altering DNA methylation and cellular metabolism [160]. The gene discussed is IDH2; the disease is acute myeloid leukemia.